Policy Notices

• Reminder to AHRQ Grantees that FY2018 Funds will Expire on September 30, 2023
  (NOT-HS-23-002)
  Agency for Healthcare Research and Quality
  

• AHRQ Announces Interest in Healthcare Associated Infections and Combating Antibiotic Resistant Bacteria Research
  (NOT-HS-23-003)
  Agency for Healthcare Research and Quality
  

• This Notice is to expire PA-20-068 "Improving Quality of Care and Patient Outcomes During Care Transitions (R01)"
  (NOT-HS-23-004)
  Agency for Healthcare Research and Quality
  

General Notices

• Notice to Extend the Response Date for NOT-AR-22-023 "Request for Information (RFI) on the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Strategic Plan for Fiscal Years (FYs) 2025-2029"
  (NOT-AR-23-007)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Technical Assistance Webinar for Potential Applicants to RFA-CA-23-013, Transformative Educational Advancement and Mentoring Network (TEAM) (R25 Clinical Trial Not Allowed)
  (NOT-CA-23-013)
  National Cancer Institute
  

• Notice RFA-DK-22-010 "Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)" Is Being Reissued
  (NOT-DK-23-001)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice RFA-DK-22-015 Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed) is Being Reissued
  (NOT-DK-23-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of a Question and Answer "Office Hour" with NIGMS Staff for IMSD and G-RISE Applicants
  (NOT-GM-23-020)
  National Institute of General Medical Sciences
  

• Notice of Information on NIMH's Considerations for Research Involving Psychedelics and Related Compounds
  (NOT-MH-23-125)
  National Institute of Mental Health
  

• Showcase Opportunities for NIH Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Awardees
  (NOT-OD-23-019)
  Office of the Director, NIH
  

• Human Subjects Research: Policies, Inclusion, & Clinical Trials Free 2-Day Virtual Event with NIH & HHS Experts December 6-7, 2022
  (NOT-OD-23-021)
  National Institutes of Health
  

• Notice of Future Research Opportunity Announcement for All of Us Research Participant and Partner Services Center
  (NOT-PM-23-001)
  Office of the Director, NIH
  

• Request for Information: Soliciting Public Comment on Draft Amyotrophic Lateral Sclerosis (ALS) Strategic Plan
  (NOT-NS-23-041)
  National Institute of Neurological Disorders and Stroke
  

Notice of Changes to Funding Opportunities

• Notice of NIAMS Participation in PAR-20-089, "Biomedical Data Repository (U24 - Clinical Trials Not Allowed)"
  (NOT-AR-23-010)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of NIAMS Participation in PAR-20-097, "Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)"
  (NOT-AR-23-011)
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  

• Notice of Change to Application Due Dates and deletion of the Introduction to Application Section for RFA-DK-22-019
  (NOT-DK-23-003)
  National Institute of Diabetes and Digestive and Kidney Diseases
  

• Notice of Early Expiration of RFA-HG-21-001, Technology Development for Single-Molecule Protein Sequencing (R01 Clinical Trial Not Allowed)" & RFA-HG-21-002, Technology Development for Single-Molecule Protein Sequencing (R21 Clinical Trial Not Allowed)"
  (NOT-HG-23-013)
  National Human Genome Research Institute
  

• Notice of Change in Page Limitations for PAR-22-194 "NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)"
  (NOT-HL-22-056)
  National Heart, Lung, and Blood Institute
  

Notices of Intent to Publish

• Notice of Intent to Publish a Funding Opportunity Announcement for NIH Brain Development Cohorts Biospecimen Access (X01 Clinical Trial Not Allowed)
  (NOT-DA-22-064)
  National Institute on Drug Abuse
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Entry-Level Modules (ELM) for Training the Genomics Research Workforce (UE5-Clinical Trial Not Allowed)
  (NOT-HG-23-014)
  National Human Genome Research Institute
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
  (NOT-MH-23-135)
  National Institute of Mental Health
  

• Notice of Intent to Publish a Funding Opportunity Announcement for Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
  (NOT-MH-23-136)
  National Institute of Mental Health
  

Notices of Special Interest

• Notice of Special Interest (NOSI): Administrative Supplement for NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT)
  (NOT-CA-23-012)
  National Cancer Institute
  

• Notice of Special Interest (NOSI): Chemsex and HIV: prevalence, medical/psychosocial consequences, and treatment
  (NOT-DA-24-002)
  National Institute on Drug Abuse
  

• Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
  (NOT-OD-23-002)
  Office of the Director, NIH
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of General Medical Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  National Library of Medicine
  Office of Behavioral and Social Sciences Research
  Office of Research on Women's Health
  

• Notice of Special Interest (NOSI): Administrative Supplement for Research and Capacity Building Efforts Related to Bioethical Issues (Admin Supp Clinical Trial Optional)
  (NOT-OD-23-018)
  Office of the Director, NIH
  John E. Fogarty International Center
  National Center for Advancing Translational Sciences
  National Center for Complementary and Integrative Health
  National Cancer Institute
  National Eye Institute
  National Human Genome Research Institute
  National Heart, Lung, and Blood Institute
  National Institute on Aging
  National Institute on Alcohol Abuse and Alcoholism
  National Institute of Allergy and Infectious Diseases
  National Institute of Arthritis and Musculoskeletal and Skin Diseases
  National Institute of Biomedical Imaging and Bioengineering
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Institute of Dental and Craniofacial Research
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute of Environmental Health Sciences
  National Institute of Mental Health
  National Institute on Minority Health and Health Disparities
  National Institute of Neurological Disorders and Stroke
  National Institute of Nursing Research
  National Library of Medicine
  Office of Research on Women's Health
  

Funding Opportunities

• Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
  (PAR-24-022)
  National Institute of Biomedical Imaging and Bioengineering
  National Eye Institute
  National Institute on Aging
  Application Receipt Date(s): Multiple dates, see announcement.
  
  

• Cooperative Centers on Human Immunology (U19 Clinical Trial Optional)
  (RFA-AI-22-069)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): April 07, 2023
  
  

• NCI Cancer Screening Research Network: ACCrual, Enrollment, and Screening Sites (ACCESS) Hub (UG1 Clinical Trial Required)
  (RFA-CA-23-020)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
  
  

• NCI Cancer Screening Research Network: Statistics and Data Management Center (UG1 Clinical Trial Required)
  (RFA-CA-23-021)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
  
  

• NCI Cancer Screening Research Network: Coordinating and Communication Center (UG1 Clinical Trial Required)
  (RFA-CA-23-022)
  National Cancer Institute
  Application Receipt Date(s): February 28, 2023
  
  

• HEAL Initiative: Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program (R01 Clinical Trial Optional)
  (RFA-DA-23-059)
  National Institute on Drug Abuse
  National Center for Complementary and Integrative Health
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 10, 2023
  
  

• HEAL Initiative - Sleep Predictors of Opioid-Use Disorder Treatment Outcomes Program: Leadership and Data Co-ordinating Center (U01 Clinical Trial Optional)
  (RFA-DA-23-060)
  National Institute on Drug Abuse
  National Heart, Lung, and Blood Institute
  National Institute on Alcohol Abuse and Alcoholism
  Application Receipt Date(s): February 10, 2023
  
  

• Exploratory studies to investigate mechanisms of HIV infection, replication, latency, and/or pathogenesis in the context of substance use disorders (R61/R33 - Clinical Trial Not Allowed)
  (RFA-DA-24-002)
  National Institute on Drug Abuse
  Application Receipt Date(s): March 23, 2023
  
  

• Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24 Clinical Trial Not Allowed)
  (RFA-DK-23-002)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Heart, Lung, and Blood Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 12, 2023
  
  

• Interventions that Address Structural Racism to Reduce Kidney Health Disparities Research Coordinating Center (U24 - Clinical Trial Not Allowed)
  (RFA-DK-23-003)
  National Institute of Diabetes and Digestive and Kidney Diseases
  National Institute on Minority Health and Health Disparities
  National Institute of Nursing Research
  Office of Disease Prevention
  Application Receipt Date(s): January 12, 2023
  
  

• Environmental Health Sciences Core Centers (EHSCC) (P30 Clinical Trial Optional)
  (RFA-ES-22-010)
  National Institute of Environmental Health Sciences
  Application Receipt Date(s): Multiple dates, see announcement.